Vaccines: News and Research on BNT162 Vaccine

MeSH tree: D20.215.894.865.450.500.750

When promising cures collapse before they reach patients

Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the COVID-19 pandemic. The world needed a vaccine that didn't exist, and there was no clear timeline for one. ...

Booster shots reduce the risks of COVID-19 deaths, study finds

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research, led by the universities of Bristol ...

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized in mRNA technology with the goal of advancing cancer treatments.

page 1 from 11